Detalles de la búsqueda
1.
Efficacy and safety of vonoprazan-based dual therapy and esomeprazole-based dual therapy in eradicating primary Helicobacter pylori infection: A propensity score matching analysis.
Helicobacter
; 28(5): e13003, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37565458
2.
Eradication rates of Helicobacter pylori in treatment-naive patients following 14-day vonoprazan-amoxicillin dual therapy: A multicenter randomized controlled trial in China.
Helicobacter
; 28(4): e12970, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37160689
3.
Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition).
Gut
; 71(2): 238-253, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34836916
4.
10-Day and 14-day high-dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis.
Helicobacter
; 26(5): e12833, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34318966
5.
SHARPIN stabilizes ß-catenin through a linear ubiquitination-independent manner to support gastric tumorigenesis.
Gastric Cancer
; 24(2): 402-416, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159601
6.
Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori.
Am J Gastroenterol
; 114(3): 437-445, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30807294
7.
Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori.
BMC Microbiol
; 19(1): 176, 2019 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31382897
8.
Comparison of procedural sequences in same-day painless bidirectional endoscopy: Single-center, prospective, randomized study.
Dig Endosc
; 29(3): 330-337, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28211094
9.
A Large Cavernous Hemangioma of Esophagus.
Am J Gastroenterol
; 116(2): 236, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32467504
10.
A 21-35 kDa Mixed Protein Component from Helicobacter pylori Activates Mast Cells Effectively in Chronic Spontaneous Urticaria.
Helicobacter
; 21(6): 565-574, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27061753
11.
Etomidate-remifentanil is more suitable for monitored anesthesia care during gastroscopy in older patients than propofol-remifentanil.
Med Sci Monit
; 21: 1-8, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25553506
12.
Correction: Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori.
Am J Gastroenterol
; 114(5): 835, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30946040
13.
Efficacy and safety of esomeprazole with flupentixol/melitracen in treating gastroesophageal reflux disease patients with emotional disorders.
J Gastroenterol Hepatol
; 29(6): 1200-6, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24955450
14.
Comparison of the efficacy between the dual therapy of tegoprazan and the quadruple therapy of tegoprazan: A randomized, controlled, multicenter study.
Clin Transl Gastroenterol
; 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38557975
15.
Unsedated transnasal upper gastrointestinal endoscopy has favorable diagnostic effectiveness, cardiopulmonary safety, and patient satisfaction compared with conventional or sedated endoscopy.
Surg Endosc
; 26(12): 3565-72, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22976847
16.
Prediction of Esophageal Stricture after Endoscopic Submucosal Dissection in Patients with Early Esophageal Cancer.
J Gastrointest Surg
; 26(12): 2434-2443, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36219368
17.
High-dose dual therapy versus culture-based susceptibility-guided therapy as a rescue regimen for Helicobacter pylori infection: a randomized controlled trial.
Therap Adv Gastroenterol
; 15: 17562848221145566, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36600682
18.
Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial.
Therap Adv Gastroenterol
; 15: 17562848221142925, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36600686
19.
High dose PPI-amoxicillin dual therapy for the treatment of Helicobacter pylori infection: a systematic review with meta-analysis.
Therap Adv Gastroenterol
; 13: 1756284820937115, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33110448
20.
Efficacy of modified esomeprazole-amoxicillin dual therapies for Helicobacter pylori infection: an open-label, randomized trial.
Eur J Gastroenterol Hepatol
; 32(5): 563-568, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31851093